Agilent Technologies (NYSE:A) Shares Gap Up After Better-Than-Expected Earnings

Agilent Technologies, Inc. (NYSE:A)’s stock price gapped up prior to trading on Thursday following a stronger than expected earnings report. The stock had previously closed at $115.84, but opened at $133.00. Agilent Technologies shares last traded at $133.0660, with a volume of 1,257,004 shares trading hands.

The medical research company reported $1.49 EPS for the quarter, topping the consensus estimate of $1.41 by $0.08. The business had revenue of $1.84 billion for the quarter, compared to the consensus estimate of $1.80 billion. Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The firm’s revenue was up 10.0% compared to the same quarter last year. During the same quarter last year, the business posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th will be issued a dividend of $0.255 per share. This represents a $1.02 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Tuesday, June 30th. Agilent Technologies’s payout ratio is 22.52%.

Key Agilent Technologies News

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent beat Wall Street’s Q2 expectations, reporting adjusted EPS of $1.49 versus estimates around $1.41 and revenue of $1.83 billion, above forecasts, with revenue up 10% year over year. Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: The company raised its full-year 2026 profit outlook and also issued Q3 guidance that points to continued growth, reinforcing confidence in demand for its lab tools and diagnostic products. Agilent raises 2026 profit forecast on strong demand for lab tools
• Positive Sentiment: Bank of America upgraded Agilent from neutral to buy, which typically helps sentiment because it signals improved confidence in the stock’s upside. Benzinga report on Bank of America upgrade
• Positive Sentiment: RBC also initiated coverage with an outperform rating and a $153 price target, adding another bullish analyst call after earnings. Benzinga report on RBC coverage
• Neutral Sentiment: Agilent also highlighted new product launches and digital-lab tools, including OpenLab Sync and new GC systems, which support the longer-term growth story but are less likely to move the stock immediately. Agilent Introduces OpenLab Sync

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on A shares. Morgan Stanley lowered their target price on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a research note on Tuesday, March 3rd. UBS Group reduced their price target on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a report on Thursday, February 26th. Wells Fargo & Company lowered their price objective on shares of Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating for the company in a research report on Thursday, February 26th. Barclays dropped their price objective on shares of Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating on the stock in a report on Tuesday, April 14th. Finally, TD Cowen cut their price objective on shares of Agilent Technologies from $170.00 to $157.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, Agilent Technologies presently has a consensus rating of “Buy” and an average target price of $161.07.

Institutional Investors Weigh In On Agilent Technologies

Several institutional investors have recently bought and sold shares of A. Bridgefront Capital LLC bought a new stake in shares of Agilent Technologies in the third quarter worth $1,323,000. Wellington Management Group LLP boosted its holdings in Agilent Technologies by 4.8% during the third quarter. Wellington Management Group LLP now owns 9,380,521 shares of the medical research company’s stock worth $1,203,990,000 after purchasing an additional 433,342 shares during the last quarter. Envestnet Asset Management Inc. grew its position in Agilent Technologies by 3.8% in the third quarter. Envestnet Asset Management Inc. now owns 607,914 shares of the medical research company’s stock valued at $78,026,000 after purchasing an additional 22,498 shares in the last quarter. Generation Investment Management LLP boosted its stake in shares of Agilent Technologies by 10.1% during the 3rd quarter. Generation Investment Management LLP now owns 6,357,953 shares of the medical research company’s stock worth $816,043,000 after buying an additional 582,093 shares during the last quarter. Finally, Champlain Investment Partners LLC boosted its stake in shares of Agilent Technologies by 33.3% during the 3rd quarter. Champlain Investment Partners LLC now owns 895,770 shares of the medical research company’s stock worth $114,972,000 after buying an additional 223,750 shares during the last quarter.

Agilent Technologies Price Performance

The company has a market cap of $38.01 billion, a P/E ratio of 29.73, a PEG ratio of 2.42 and a beta of 1.22. The company has a fifty day moving average price of $114.99 and a two-hundred day moving average price of $128.79. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.59 and a current ratio of 2.07.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.